News | December 24, 2021
Indian Pharmaceutical Market grew at 6.6 pc in November
Flattish volume growth and subdued new launches were key factors for last month
Flattish volume growth and subdued new launches were key factors for last month
Contribution from the top five therapies stood at 58% of IPM in October 2021. These therapies are cardiac, anti-infectives, gastro-intestinal, anti-diabetic and vitamins
The approval is for Cytomegalovirus, a type of Herpes virus
The group now has 324 approvals and has so far filed over 400 ANDAs
The NFI is published to promote the rational use of medicines in the country.
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
These were the findings of the Post Marketing Surveillance (PMS), study of Favipiravir (FabiFlu) on over 1000 patients
The segment delivered strong sales growth of 20% YoY
WHO prequalification enables the procurement of ROTAVAC 5D by UN agencies namely UNICEF and PAHO
The study was conducted in patients with mild to moderate COVID-19
Subscribe To Our Newsletter & Stay Updated
